Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1996Antimicrobial Agents and ChemotherapyOpen Access

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

View Full Paper
Ask AI
Bookmark
Share

Authors

GZGary E. ZurenkoUniversity of Southern CaliforniaBYBetty H. YagiKalamazoo CollegeRSRonda D. SchaadtKalamazoo College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zurenko et al. (1996) studied this question.

synapsesocial.com/papers/6a65a0c666b3f59c44c4d9dchttps://doi.org/10.1128/aac.40.4.839
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1National Committee for Clinical Laboratory Standards1980 · 14,792 citations
  2. 2In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents1988 · 29 citations
  3. 3Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall1980 · 100 citations
  4. 4Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds1988 · 62 citations
  5. 5In-vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones1988 · 19 citations